RxDoctor Payments Data

Micca Schneider, MD

Family Medicine · Great Bend, KSNPI 1013400431

Payments from drug & device makers

$294in general payments, 2019–2025

Across 17 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$45
  • Novo Nordisk$44
  • Grifols USA, LLC$32
  • Amgen$31
  • Dexcom, Inc.$20
  • Pfizer$20
  • plus $102 from 6 others

What the payments were for

  • Food & beverage$294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$294 in reported general payments places this provider in the 40th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$4,506
Medicare patients
14
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$50,200
JardianceEmpagliflozin34$35,500
OzempicSemaglutide39$32,189
JanuviaSitagliptin Phosphate37$26,934
MyrbetriqMirabegron36$25,593
XareltoRivaroxaban33$18,164
TrulicityDulaglutide17$15,979
MounjaroTirzepatide14$14,160
FarxigaDapagliflozin Propanediol15$11,492
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,202
Breo ElliptaFluticasone/Vilanterol16$6,706
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$5,786
Pantoprazole Sodium285$3,444
Rosuvastatin Calcium287$2,321
SynthroidLevothyroxine Sodium23$2,302

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$50,20049 claims
Novo NordiskOzempic$44$32,18939 claims
Lilly USA, LLCTrulicity, Mounjaro$17$30,13931 claims
GSKTrelegy Ellipta, Breo Ellipta$17$16,90833 claims
AbbVieSynthroid$45$2,30223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Great Bend

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →